Cardiac regeneration: The gene therapy approach

Expert Opinion on Biological Therapy

Volumn 9, Issue 4, 2009, Pages 411-425

  Laguens, Rubén P ^a   Crottogini, Alberto J ^a  

^a FAVALORO UNIVERSITY   (Argentina)

Author keywords

Adult cardiomyocyte; Cardiomyocyte cell cycle; Cardiomyogenesis; Gene therapy; Gene transfer

Indexed keywords

6 BROMOINDIRUBIN 30 OXIME; BETA CATENIN; CDC5 PROTEIN; CYCLIN A2; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; E1A PROTEIN; E1B PROTEIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 5; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NUCLEAR LOCALIZING SIGNAL TAGGED CYCLIN D1; PHOSPHOTRANSFERASE INHIBITOR; S PHASE KINASE ASSOCIATED PROTEIN 2; SOMATOMEDIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; VIRUS T ANTIGEN;

CELL ACTIVATION; CELL CYCLE REGULATION; CELL POPULATION; CELL PROLIFERATION; CELL REGENERATION; CELL STIMULATION; CYTOKINESIS; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEART; HEART DEVELOPMENT; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; MITOSIS; MUSCLE DEVELOPMENT; NONHUMAN; POSTNATAL GROWTH; REVIEW; TARGET CELL; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; GENE THERAPY; HUMANS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; REGENERATION;

MAMMALIA; MUS; RATTUS; RODENTIA;

EID: 67649268404     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590902806364     Document Type: Review

References (115)

1. Sutton M, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 2000;101:2981-2988 (Pubitemid 30415891)
2. Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt Sinai J Med 2006;73:840-851 (Pubitemid 44768620)
3. Lenderink T, Simoons ML, Van Es GA, et al. Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group. Circulation 1995;92:1110-1116
4. Pfeffer JM, Pfeffer MA, Fletcher PJ, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol 1991;260:H1406-14
5. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-262 (Pubitemid 29056953)
6. Lopez A, Murray C. The global burden of disease, 1990-2020. Nat Med 1998;4:1241-1243
7. Jessup M, Brozena S. Heart failure. N Engl J Med 2003;348:2007-2018
8. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002;347:1397-1402 (Pubitemid 35239711)
9. McMurray JJ, Pfeffer MA. Heart failure. Lancet 2005;365:1877-1889 (Pubitemid 40744967)
10. Stevenson LW. Design of therapy for advanced heart failure. Eur J Heart Fail 2005;7:323-331 (Pubitemid 40249524)
11. Khand A, Gemmel I, Clark AL, Cleland JG. Is the prognosis of heart failure improving? J Am Coll Cardiol 2000;36:2284-2286
12. Konstam MA. Progress in heart failure management? Lessons from the real world. Circulation 2000;102:1076-1078 (Pubitemid 30672831)
13. Mallory GK, White PD, Salcedo-Salgar J. The speed of healing of myocardial infarction: a study of the pathologic anatomy in 72 cases. Am Heart J 1939;18:647-671
14. Zak R. Cell proliferation during cardiac growth. Am J Cardiol 1973;31:211-219
15. Ueno H, Perryman M, Roberts R, Schneider MD. Differentiation of cardiac myocytes after mitogen withdrawal exhibits three sequential states of the ventricular growth response. J Cell Biol 1988;107:1911-1918
16. Poolman RA, Brooks G. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J Mol Cell Cardiol 1998;30:2121-2135 •• A detailed study of the cyclins and cyclin-dependent kinases involved in withdrawal from the cell cycle and responsible for maintenance of hypertrophic growth. (Pubitemid 28495337)
17. Brooks G, Poolman RA, Li JM. Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors. Cardiovasc Res 1998;39:301-311 (Pubitemid 28346526)
18. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276-1283 (Pubitemid 29489744)
19. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 1989;84:1693-1700 (Pubitemid 20016170)
20. Tam SK, Gu W, Mahdavi V, et al. Cardiac myocyte terminal differentiation. Potential for cardiac regeneration. Ann NY Acad Sci 1995;752:72-79
21. Von Harsdorf R. Can cardiomyocytes divide? Heart 2001;86:481-482
22. Christoffels V, Habets P, Franco D, et al. Chamber formation and morphogenesis in the developing mammalian heart. Dev Biol 2000;223:266-278 (Pubitemid 30485592)
23. Cohn JN, Bristow MR, Chien KR, et al. Report of the National heart, lung, and blood institute special emphasis panel on heart failure research. Circulation 1997;95:766-770 (Pubitemid 27091506)
24. Laflamme M, Gold J, Xu C, et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005;167:663-671 (Pubitemid 41216352)
25. Lyngbaek S, Schneider M, Hansen JL, Sheikh SP. Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Res Cardiol 2007;102:101-114 (Pubitemid 46193950)
26. Kajstura J, Urbanek K, Rota M, et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 2008;45:505-513
27. Reinecke H, Minami E, Zhu WZ, Laflamme MA. Cardiogenic differentiation and transdifferentiation of progenitor cells. Circ Res 2008;103:1058-1071
28. Strauer BE, Brehm M, Schannwell CM. The therapeutic potential of stem cells in heart disease. Cell Prolif 2008;41(Suppl 1):126-145 (Pubitemid 350295849)
29. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008;451:937-942 (Pubitemid 351301749)
30. Penn MS, Khalil MK. Exploitation of stem cell homing for gene delivery. Expert Opin Biol Ther 2008;8:17-30 (Pubitemid 351233720)
31. Guan K, Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes? J Mol Cell Cardiol 2007;43:377-387
32. Brodsky WY, Arefyeva AM, Uryvaeva IV. Mitotic polyploidization of mouse heart myocytes during the first postnatal week. Cell Tissue Res 1980;210:133-144 (Pubitemid 10026125)
33. Rumyantsev P. Interrelation of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977;51:187-273 (Pubitemid 8242416)
34. Katzberg A, Farmer B, Harris R. The predominance of binucleation in isolated rat heart myocytes. Am J Anat 1977;149:489-500 (Pubitemid 8185519)
35. Brodsky VYA, Chernyaev AL, Vasilyeva IA. Variability of the cardiomyocyte ploidy in normal human hearts. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;61:289-294
36. Li F, Wang X, Capasso JM, Gerdes AM. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardioll 1996;28:1737-1746 (Pubitemid 26300573)
37. Soonpaa MH, Kim KK, Pajak L, et al. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 1996;271:H2183-9 (Pubitemid 126832265)
38. Petersen RO, Baserga R. Nucleic acid and protein synthesis in cardiac muscle of growing and adult mice. Exp Cell Res 1965;40:340-352
39. van Amerongen MJ, Engel FB. Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 2008;12:2233-2244
40. Capasso J, Bruno S, Cheng W, et al. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ Res 1992;71:1379-1389
41. Sedmera D, Thompson R, Kolar F. Effect of increased pressure loading on heart growth in neonatal rats. J Mol Cell Cardiol 2003;35:301-309 (Pubitemid 36379174)
42. Ahuja P, Perriard E, Pedrazzini T, et al. Re-expression of proteins involved in cytokinesis during cardiac hypertrophy. Exp Cell Res 2007;313:1270-1283 •• This research demonstrates the role of polyploidization in myocardial hypertrophy. (Pubitemid 46437247)
43. Soopaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis during hypertrophy in adult mice. Am J Physiol 1994;266:H1439-45 (Pubitemid 2084487)
44. Soonpaa MH, Field LJ. Assessment of cardiomyocyte DNA synthesis in normal and injured adult mouse hearts. Am J Physiol 1997;272:H220-6 (Pubitemid 27066682)
45. de Simone G, Devereux RB, Daniels ER, Meyer RA. Gender differences in left ventricular growth. Hypertension 1995;26:979-983
46. Olivetti G, Giordano G, Corradi D, et al. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995;26:1068-1079
47. Chen X, Wilson RM, Kubo H, et al. Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res 2007;100:536-544 •• Unequivocal evidence of the presence of resident myocyte progenitors and their role in postnatal development is presented. (Pubitemid 46673263)
48. Adler CP, Friedburg H, Herget GW, et al. Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts. Virchows Arch 1996;429:159-164 (Pubitemid 26378968)
49. Gräbner W, Pfitzer P. Number of nuclei in isolated myocardial cells of pigs. Virchows Arch B Cell Pathol 1974;15:279-294
50. Schmid G, Pfitzer P. Mitoses and binucleated cells in perinatal human hearts. Virchows Arch B Cell Pathol Incl Mol Pathol 1985;48:59-67 (Pubitemid 15169016)
51. Korecky B, Sweet S, Rakusan K. Number of nuclei in mammalian cardiac myocytes. Can J Physiol Pharmacol 1979;57:1122-1129 • A critical review on stem cell therapy trials in humans. (Pubitemid 10193721)
52. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res 1974;34&35(Suppl II):II-17-26
53. Novi AM. Molecular basis of a control mechanism of DNA synthesis in mammalian cells. Klin Wochenschr 1976;54:961-968
54. Vliegen HW, Bruschke AV, Van der Laarse A. Different response of cellular DNA content to cardiac hypertrophy in human and rat heart myocytes. Comp Biochem Physiol A 1990;95:109-114 (Pubitemid 20042108)
55. Ebert L, Pfitzer P. Nuclear DNA of myocardial cells in the periphery of infarctions and scars. Virchows Arch B Cell Pathol 1977;24:209-217 (Pubitemid 8159758)
56. Herget GW, Neuburger M, Plagwitz R, Adler CP. DNA content, ploidy level and number of nuclei in the human heart after myocardial infarction. Cardiovasc Res 1997;36:45-51 (Pubitemid 27463571)
57. Linzbach AJ. Hypertrophy, hyperplasia and structural dilatation of the human heart. Adv Cardiol 1976;18:1-14
58. Quaini F, Cigola E, Lagrasta C, et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res 1994;75:1050-1063 (Pubitemid 24351450)
59. Anversa P, Kajstura J, Cheng W, et al. Insulin-like growth factor-1 and myocyte growth: the danger of a dogma, II: induced myocardial growth: pathologic hypertrophy. Cardiovasc Res 1996;32:484-495
60. Anversa P, Kajstura J. Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 1998;83:1-14 (Pubitemid 28322094)
61. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001;344:1750-1757 (Pubitemid 32497029)
62. Cabeza Meckert P, García Rivello H, Vigliano C, et al. Endomitosis and polyploidization of myocardial cells in the periphery of human acute myocardial infarction. Cardiovasc Res 2005;67:116-123 (Pubitemid 40798298)
63. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res 2002;90:1044-1054 (Pubitemid 34627902)
64. Kirshenbaum LA, Abdellatif M, Chakraborty S, et al. Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Dev Biol 1996;179:402-411 (Pubitemid 26384084)
65. Agah R, Kirshenbaum LA, Abdellatif M, et al. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 1997;100:2722-2728 (Pubitemid 28007539)
66. von Harsdorf R, Hauck L, Mehrhof F, et al. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ Res 1999;85:128-136 (Pubitemid 29343311)
67. Jackson T, Allard MF, Sreenan CM, et al. Transgenic animals as a tool for studying the effect of the c-myc proto-oncogene on cardiac development. Mol Cell Biochem 1991;104:15-19
68. Xiao G, Mao S, Baumgarten G, et al. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 2001;89:1122-1129 (Pubitemid 34627869)
69. Hahn JY, Cho HJ, Bae JW, et al. β-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 2006;281:30979-30989 (Pubitemid 44582153)
70. Tseng AS, Engel FB, Keating MT. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes. Chem Biol 2006;13:957-963 (Pubitemid 44389934)
71. Kerkela R, Kockeritz L, Macaulay K, et al. Deletion of GSK-3β in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest 2008;118:3609-3618
72. Soonpaa MH, Koh GY, Pajak L, et al. Cyclin D1 overexpression promotes cardiomyocyte DNA synthesis and multinucleation in transgenic mice. J Clin Invest 1997;99:2644-2654 (Pubitemid 27259811)
73. Pasumarthi K, Nakajima H, Nakajima HO, et al. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ Res 2005;96:110-118 (Pubitemid 40095760)
74. Hassink R, Pasumarthi K, Nakajima H, et al. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction. Cardiovasc Res 2008;78:18-25 • This paper presents evidence that Cyclin D2 overexpression induces cardiomyogenesis and increased load-independent left ventricular inotropic state.
75. Tamamori-Adachi M, Takagi H, Hashimoto K, et al. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase. Cardiovasc Res 2008;80:181-190
76. Limana F, Urbanek K, Chimenti S, et al. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002;99:6257-6262 (Pubitemid 34493299)
77. Liao HS, Kang PM, Nagashima H, et al. Cardiac-specific overexpression of cyclin-dependent kinase 2 increases smaller mononuclear cardiomyocytes. Circ Res 2001;88:443-450 (Pubitemid 32200119)
78. Dätwyler D, Magyar J, Weikert C, et al. Reactivation of the mitosis-promoting factor in postmitotic cardiomyocytes. Cells Tissues Organs 2003;175:61-71 (Pubitemid 37409850)
79. Bicknell K, Coxon C, Brooks G. Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes. Biochem J 2004;382:411-416 (Pubitemid 39243906)
80. Williams SD, Zhu H, Zhang L, Bernstein HS. Adenoviral delivery of human CDC5 promotes G2/M progression and cell division in neonatal ventricular cardiomyocytes. Gene Ther 2006;13:837-843
81. Chaudhry HW, Dashoush NH, Tang H, et al. Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium. J Biol Chem 2004;279:35858-35866 (Pubitemid 39100593)
82. Woo Y, Panlilio C, Cheng R, et al. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation 2006;114(1 Suppl):I206-13 (Pubitemid 44297152)
83. Cheng R, Asai T, Tang H, et al. Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure. Circ Res 2007;100:1741-1748 (Pubitemid 46987866)
84. Reiss K, Cheng W, Ferber A, et al. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci USA 1996;93:8630-8635 (Pubitemid 26269611)
85. Santini MP, Tsao L, Monassier L, et al. Enhancing repair of the mammalian heart. Circ Res 2007;100:1732-1740 (Pubitemid 46987865)
86. Sen A, Dunnmon P, Henderson SA, et al. Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem 1988;263:19132-19136 (Pubitemid 19016380)
87. Kirshenbaum LA, Schneider MD. Adenovirus E1A represses cardiac gene transcription and reactivates DNA synthesis in ventricular myocytes, via alternative pocket protein- and p300-binding domains. J Biol Chem 1995;270:7791-7794
88. MacLellan WR, Garcia A, Oh H, et al. Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol 2005;25:2486-2497 (Pubitemid 40354641)
89. Poolman RA, Li JM, Durand B, et al. Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice. Circ Res 1999;85:117-127 (Pubitemid 29343310)
90. Nakajima H, Nakajima HO, Tsai S, Field L. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice. Circ Res 2004;94:1606-1614 (Pubitemid 38856968)
91. Engel FB, Schebesta M, Duong MT, et al. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev 2005;19:1175-1187 (Pubitemid 40696184)
92. Engel FB, Hsieh PCH, Lee RT, Keating MT. FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc Natl Acad Sci USA 2006;103:15546-15551 •• Evidence that combined cell cycle manipulation therapy induces adult cardiomyocyte mitosis is presented. (Pubitemid 44625629)
93. Engel FB, Schebesta M, Keating MT. Anillin localization defect in cardiomyocyte binucleation. J Mol Cell Cardiol 2006;41:592-594 (Pubitemid 44374532)
94. Laguens R, Cabeza Meckert P, Vera Janavel G, et al. Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer. Gene Ther 2002;9:1676-1681 (Pubitemid 36104611)
95. Crottogini A, Cabeza Meckert P, Vera Janavel G, et al. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther 2003;14:1307-1318 (Pubitemid 37174755)
96. Laguens R, Cabeza Meckert P, Vera Janavel G, et al. Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med 2004;6:222-227 (Pubitemid 40232984)
97. Vera Janavel G, Crottogini A, Cabeza Meckert P, et al. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther 2006;13:1133-1142 (Pubitemid 44101363)
98. Claycomb WC, Moses RL. Growth factors and TPA stimulate DNA synthesis and alter the morphology of cultured terminally differentiated adult rat cardiac muscle cells. Dev Biol 1988;127:257-265 (Pubitemid 18156387)
99. Decker RS, Cook MG, Behnke-Barclay M, Decker ML. Some growth factors stimulate cultured adult rabbit ventricular myocyte hypertrophy in the absence of mechanical loading. Circ Res 1995;77:544-555
100. Seko Y, Takahashi N, Tobe K, et al. Vascular endothelial growth factor (VEGF) activates Raf-1, mitogen-activated protein (MAP) kinases, and S6 kinase (p90rsk) in cultured rat cardiac myocytes. J Cell Physiol 1998;175:239-246 (Pubitemid 28198203)
101. Takahashi N, Seko Y, Noiri E, et al. Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Circ Res 1999;84:1194-1202 (Pubitemid 29244781)
102. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346:5-15 (Pubitemid 34438914)
103. Anversa P, Nadal-Ginard B. Myocyte renewal and ventricular remodelling. Nature 2002;415:240-243 (Pubitemid 34059531)
104. Ferrarini M, Arsic N, Recchia FA, et al. Adeno-associated virus-mediated tansduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs. Circ Res 2006;98:954-961 (Pubitemid 43755249)
105. Liu X, Chen Y, Zhang F, et al. Synergistically therapeutic effects of VEGF165 and angiopoietin-1 on ischemic rat myocardium. Scand Cardiovasc J 2007;41:95-101 (Pubitemid 46605384)
106. Suzuki G, Lee TC, Fallavollita JA, et al. Adenoviral gene transfer of FGF-5 to hibernating myocardium improves function and stimulates myocytes to hypertrophy and reenter the cell cycle. Circ Res 2005;96:767-775 (Pubitemid 40559516)
107. Lynch P, Lee TC, Fallavollita JA, et al. Intracoronary administration of AdvFGF-5 (fibroblast growth factor-5) ameliorates left ventricular dysfunction and prevents myocyte loss in swine with developing collaterals and ischemic cardiomyopathy. Circulation 2007;116(1 Suppl):I71-6 (Pubitemid 47480772)
108. Zou Y, Takano H, Mizukami M, et al. Leukemia inhibitory factor enhances survival of cardiomyocytes and induces regeneration of myocardium after myocardial infarction. Circulation 2003;108:748-753 (Pubitemid 36999262)
109. Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007;167:989-997 •• A critical review on stem cell therapy trials in humans. (Pubitemid 46835786)
110. Ince H. Petzsch M, Rehders TC, et al. Transcatheter transplantation of autologous skeletal myoblasts in postinfarction patients with severe left ventricular dysfunction. J Endovasc Ther 2004;11:695-704 (Pubitemid 40110747)
111. Gavira JJ, Herreros J, Perez A, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg 2006;131:799-804
112. Stamm C, Kleine HD, Choi YH, et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-725 (Pubitemid 46274739)
113. Tatsumi T, Ashihara E, Yasui T, et al. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J 2007;71:1199-1207 (Pubitemid 47201778)
114. Strauer BE, Brehm M, Zeus T, et al. Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005;46:1651-1658 (Pubitemid 41531618)
115. Gorr TA, Deten A. Manipulating myocyte cell cycle control for cardiac repair. Cardiovasc Res 2008;80:161-162